Coagulation abnormalities in Legg-Calvé-Perthes disease

Journal of Bone and Joint Surgery

Volumn 92, Issue 1, 2010, Pages 121-128

  Vosmaer, A ^a   Rodrigues Pereira, R ^b   Koenderman, J S ^c   Rosendaal, F R ^c   Cannegieter, S C ^c  

^a IKAZIA HOSPITAL   (Netherlands)

^b Maasstad Hospital Rotterdam   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADOLESCENT; ARTICLE; BLOOD CLOTTING DISORDER; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION; NETHERLANDS; PERTHES DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK FACTOR; SCHOOL CHILD; THROMBOPHILIA; VEIN THROMBOSIS; GENETICS; INFANT; SEX DIFFERENCE;

ADOLESCENT; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEGG-PERTHES DISEASE; MALE; RISK FACTORS; SEX FACTORS; THROMBOPHILIA;

EID: 73949119762     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.I.00157     Document Type: Article

References (34)

1. Catterall A. The natural history of Perthes' disease. J Bone Joint Surg Br. 1971;53:37-53.
2. Arruda VR, Belangero WD, Ozelo MC, Oliveira GB, Pagnano RG, Volpon JB, Annichino-Bizzacchi JM. Inherited risk factors for thrombophilia among children with Legg-Calvé-Perthes disease. J Pediatr Orthop. 1999;19:84-7.
3. Glueck CJ, Glueck HI, Greenfield D, Freiberg R, Kahn A, Hamer T, Stroop D, Tracy T. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease. Pediatr Res. 1994;35(4 Pt 1):383-8. (Pubitemid 24096580)
4. Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. J Bone Joint Surg Am. 1996;78:3-13.
5. Glueck CJ, Brandt G, Gruppo R, Crawford A, Roy D, Tracy T, Stroop D, Wang P, Becker A. Resistance to activated protein C and Legg-Perthes disease. Clin Orthop Relat Res. 1997;338:139-52. (Pubitemid 27203459)
6. Balasa VV, Gruppo RA, Glueck CJ, Wang P, Roy DR, Wall EJ, Mehlman CT, Crawford AH. Legg-Calve-Perthes disease and thrombophilia. J Bone Joint Surg Am. 2004;86:2642-7.
7. Eldridge J, Dilley A, Austin H, EL-Jamil M, Wolstein L, Doris J, Hooper WC, Meehan PL, Evatt B. The role of protein C, protein S, and resistance to activated protein C in Legg-Perthes disease. Pediatrics. 2001;107:1329-34.
8. López-Franco M, González-Morán G, De Lucas JC Jr, Llamas P, de Velasco JF, Vivancos JC, Epeldegui-Torre T. Legg-Perthes disease and heritable thrombophilia. J Pediatr Orthop. 2005;25:456-9.
9. Pósán E, Szepesi K, Gáspár L, Csernátony Z, Hársfalvi J, Ajzner E, Tóth A, Udvardy M. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis. 2003;14:243-8.
10. Szepesi K, Pósán E, Hársfalvi J, Ajzner E, Szücs G, Gáspár L, Csernátony Z, Udvardy M. The most severe forms of Perthes' disease associated with the homozygous Factor V Leiden mutation. J Bone Joint Surg Br. 2004;86:426-9. (Pubitemid 38559497)
11. Thomas DP, Morgan G, Tayton K. Perthes' disease and the relevance of thrombophilia. J Bone Joint Surg Br. 1999;81:691-5.
12. Gallistl S, Reitinger T, Linhart W, Muntean W. The role of inherited thrombotic disorders in the etiology of Legg-Calvé-Perthes disease. J Pediatr Orthop. 1999;19:82-3. (Pubitemid 29005611)
13. Hayek S, Kenet G, Lubetsky A, Rosenberg N, Gitel S, Wientroub S. Does thrombophilia play an aetiological role in Legg-Calvé-Perthes disease? J Bone Joint Surg Br. 1999;81:686-90.
14. Hresko MT, McDougall PA, Gorlin JB, Vamvakas EC, Kasser JR, Neufeld EJ. Prospective reevaluation of the association between thrombotic diathesis and Legg-Perthes disease. J Bone Joint Surg Am. 2002;84:1613-8.
15. Kealey WD, Mayne EE, McDonald W, Murray P, Cosgrove AP. The role of coagulation abnormalities in the development of Perthes' disease. J Bone Joint Surg Br. 2000;82:744-6.
16. Koo KH, Song HR, Ha YC, Kim JR, Kim SJ, Kim KI, Chang KC, Ahn IO, Cho SH. Role of thrombotic and fibrinolytic disorders in the etiology of Perthes' disease. Clin Orthop Relat Res. 2002;399:162-7.
17. Mehta JS, Conybeare ME, Hinves BL, Winter JB. Protein C levels in patients with Legg-Calve-Perthes disease: is it a true deficiency? J Pediatr Orthop. 2006;26:200-3.
18. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet. 1993;342:1503-6.
19. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-7. (Pubitemid 24144355)
20. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-703.
21. Deutz-Terlouw PP, Ballering L, van Wijngaarden A, Bertina RM. Two ELISA's for measurement of protein S, and their use in the laboratory diagnosis of protein S deficiency. Clin Chim Acta. 1990;186:321-34.
22. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152-5.
23. Clauss A. [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol. 1957;17:237-46. German.
24. Jensen T, Halvorsen S, Godal HC, Sandset PM, Skjøonsberg OH. Discrepancy between fibrinogen concentrations determined by clotting rate and clottability assays during the acute-phase reaction. Thromb Res. 2000;100:397-403.
25. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251-3.
26. Andrew M. Developmental hemostasis: relevance to hemostatic problems during childhood. Semin Thromb Hemost. 1995;21:341-56. (Pubitemid 26010005)
27. Gruppo R, Glueck CJ, Wall E, Roy D, Wang P. Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the factor V Leiden mutation. J Pediatr. 1998;132:885-8.
28. Dilley A, Hooper WC, Austin H, Jamil M, Miller C, Stokes M, Evatt B, Eldridge J. The beta fibrinogen gene G-455-A polymorphism is a risk factor for Legg-Perthes disease. J Thromb Haemost. 2003;1:2317-21.
29. Liu SL, Ho TC. The role of venous hypertension in the pathogenesis of Legg-Perthes disease. A clinical and experimental study. J Bone Joint Surg Am. 1991;73:194-200.
30. Gregosiewicz A, Okoński M, Stolecka D, Kandzierski G, Szponar M. Ischemia of the femoral head in Perthes' disease: is the cause intra- or extravascular? J Pediatr Orthop. 1989;9:160-2.
31. Trueta J. The normal vascular anatomy of the human femoral head during growth. J Bone Joint Surg Br. 1957;39:358-94.
32. Liesner RJ. Does thrombophilia cause Perthes' disease in children? J Bone Joint Surg Br. 1999;81:565-6.
33. Chung SM. The arterial supply of the developing proximal end of the human femur. J Bone Joint Surg Am. 1976;58:961-70.
34. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res. 2005;435:164-70.